Human Papillomavirus (HPV)

Recent News

Aug 24, 2018
Throat exam

CDC: Mouth area now most common site of HPV-linked cancer

The oropharyngeal cancer rate increased 2.8% per year in men and 0.6% in women.

Aug 22, 2018

News Scan for Aug 22, 2018

HPV vaccine and premature menopause
Cyclospora expert panel
Aug 21, 2018

News Scan for Aug 21, 2018

HPV and cervical cancer
H7N9 in smuggled poultry
Aug 20, 2018
Couple outdoors man smoking

UK study bolsters HPV infection link to smoking, sexual activity

Former smokers had triple the risk, while those with more than 6 sex partners had a sixfold risk.

Aug 08, 2018
HPV vaccination

Study: Catch-up HPV vaccination effective until age 20

The results confirm, however, that the vaccine is most effective when given at younger ages.

Jul 19, 2018

News Scan for Jul 19, 2018

Low UK flu vaccine protection
FDA mulls sole-source drug supply
Evaluating Ebola vaccine
Ebola medical treatments
HPV vaccine in boys, men
Jun 14, 2018

News Scan for Jun 14, 2018

More suspected DRC Ebola
Salmonella egg outbreak
HPV vaccination messaging
Manure-related E coli illness
May 09, 2018

News Scan for May 09, 2018

More romaine E coli cases
Predicting pandemic severity
Lassa fever cases
HPV vaccine meta-analysis
May 07, 2018

News Scan for May 07, 2018

Largest-ever cholera vaccine drive
Hepatitis A across US
Low HPV vaccine uptake
Mar 23, 2018

News Scan for Mar 23, 2018

Contact precautions and resistance
Antimicrobial use on farms
Polio in Afghanistan
HPV vaccine uptake

Resources & Literature

Recent Literature

Amorim AT, Marques LM, Campos GB, et al. Co-infection of sexually transmitted pathogens and human papillomavirus in cervical samples of women of Brazil. BMC Infect Dis 2017 Dec 15;17:769

Arbyn M, Xu L, Simoens C, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 2018 (published online May 9)

Artemchuk H, Triglav T, Ostrbenk A, et al. Seroprevalences for 11 human papillomavirus (HPV) types mark cumulative HPV exposure. J Infect Dis 2018 (published online Feb 26)

Aziz H, Iqbal H, Mahmood H, et al. Human papillomavirus (HPV) infection in females with normal cervical cytology: genotyping and phylogenetic analysis among women in Punjab, Pakistan. Int J Infect Dis 2017 (published online Nov 11)

Boyd ED, Phillips JM, Schoenberger YMM, et al. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine 2018 (published online May 21)

Canfell K, Caruana M, Gebski V, et al. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: results of the Compass pilot randomised trial. PLoS Med 2017 Sep 19;14(9):e1002388

Combes JD, Heard I, Poizot-Martin I, et al. Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men. J Infect Dis 2018 (published online Jan 31)

D'Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol 2017 (published online Oct 19)

Dempsey AF, Pyrznawoski J, Lockhart, S, et al. Effect of health care professional communication training intervention on adolescent human papillomavirus vaccination. JAMA Pediatr 2018 (published online Mar 5)

Donken R, King AJ, Bogaards JA, et al. High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females. J Infect Dis 2018 (published online Feb 2)

Eldridge RC, Pawlita M, Wilson L, et al. Smoking and subsequent HPV infection: a mediation analysis. Ann Epidemiol 2017 (published online Oct 17)

Feiring B, Laake I, Christiansen IK, et al. Substantial decline in prevalence of vaccine-type and non-vaccine type HPV in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway. J Infect Dis 2018 (published online Jul 16)

Gargano JW, Park IU, Griffin MR, et al. Trends in high-grade cervical lesions and cervical cancer screening in five states, 2008-2015. Clin Infect Dis 2018 (published online Aug 23)

Gargano JW, Zhou F, Stokley S, et al. Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States 2007-2014. Vaccine 2018 (published online May 4)

Garland SM, Pitisuttithum P, Ngan HYS, et al. Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine: subgroup analysis of participants from Asian countries. J Infect Dis 2018 (published online May 15)

Gee J, Sukumaran L, Weintraub E, et al. Risk of Guillain-Barre syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink. Vaccine 2017 (published online Sep 19)

Guo F, Cofie LE, Berenson AB. Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction.  Am J Prev Med 2018 (published online May 30)

Hanson KE, Koch B, Bonner K, et al. National trends in parental HPV vaccination intentions and reasons for hesitancy, 2010-2015. Clin Infect Dis 2018 (published online Mar 27)

Hviid A, Svanstrom H, Scheller NM, et al. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J Intern Med 2017 (published online Oct 18)

Ji Y, Ma XX, Li Z, et al. The burden of human papillomavirus and Chlamydia trachomatis coinfection in women: a large cohort study in Inner Mongolia, China. J Infect Dis 2018 (published online Sep 5)

Kavanagh K, Pollock KG, Cuschieri K, et al. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis 2017 (published online Sep 28)

Kim JJ, Burger EA, Regan C, et al. Screening for cervical cancer in primary care a decision analysis for the US Preventive Services Task Force. JAMA 2018 Aug 21;320(7):706-14

Kjaer SK, Nygard M, Dillner J, et al. A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries. Clin Infect Dis 2017 (published online Oct 1)

Kojic EM, Conley L, Bush T, et al. Prevalence and incidence of anal and cervical high-risk human papillomavirus (HPV) types covered by current HPV vaccines among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). J Infect Dis 2018 (published online Feb 14)

Konno R, Konishi H, Sauvaget C, et al. Effectiveness of HPV vaccination against high grade cervical lesions in Japan. Vaccine 2018 (published online May 21)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»